3KME

Crystal structure of catalytic domain of TACE with phenyl-pyrrolidinyl-tartrate inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free: 0.225 
  • R-Value Work: 0.200 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.

Rosner, K.E.Guo, Z.Orth, P.Shipps, G.W.Belanger, D.B.Chan, T.Y.Curran, P.J.Dai, C.Deng, Y.Girijavallabhan, V.M.Hong, L.Lavey, B.J.Lee, J.F.Li, D.Liu, Z.Popovici-Muller, J.Ting, P.C.Vaccaro, H.Wang, L.Wang, T.Yu, W.Zhou, G.Niu, X.Sun, J.Kozlowski, J.A.Lundell, D.J.Madison, V.McKittrick, B.Piwinski, J.J.Shih, N.Y.Arshad Siddiqui, M.Strickland, C.O.

(2009) Bioorg Med Chem Lett 20: 1189-1193

  • DOI: 10.1016/j.bmcl.2009.12.004
  • Primary Citation of Related Structures:  
    3KME, 3KMC

  • PubMed Abstract: 
  • A novel series of TNF-alpha convertase (TACE) inhibitors which are non-hydroxamate have been discovered. These compounds are bis-amides of L-tartaric acid (tartrate) and coordinate to the active site zinc in a tridentate manner. They are selective fo ...

    A novel series of TNF-alpha convertase (TACE) inhibitors which are non-hydroxamate have been discovered. These compounds are bis-amides of L-tartaric acid (tartrate) and coordinate to the active site zinc in a tridentate manner. They are selective for TACE over other MMP's. We report the first X-ray crystal structure for a tartrate-based TACE inhibitor.


    Organizational Affiliation

    Department of Medicinal Chemistry, Schering-Plough Research Institute Cambridge, 320 Bent Street, Cambridge, MA 02141, United States.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
TNF-alpha-converting enzymeAB270Homo sapiensMutation(s): 3 
Gene Names: ADAM17CSVPTACE
EC: 3.4.24.86
Find proteins for P78536 (Homo sapiens)
Explore P78536 
Go to UniProtKB:  P78536
NIH Common Fund Data Resources
PHAROS  P78536
Protein Feature View
Expand
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence
Small Molecules
Ligands 4 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
INN
Query on INN

Download CCD File 
A
N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide
C19 H37 N5 O5
LMIQCBIEAHJAMZ-GZBFAFLISA-N
 Ligand Interaction
Z59
Query on Z59

Download CCD File 
B
(2R,3R)-2,3-dihydroxy-4-oxo-4-[(2R)-2-phenylpyrrolidin-1-yl]-N-(thiophen-2-ylmethyl)butanamide
C19 H22 N2 O4 S
IJWSOCHVNGQZGZ-BRWVUGGUSA-N
 Ligand Interaction
ZN
Query on ZN

Download CCD File 
A, B
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
 Ligand Interaction
IPA
Query on IPA

Download CCD File 
A
ISOPROPYL ALCOHOL
C3 H8 O
KFZMGEQAYNKOFK-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
Z59Ki :  725   nM  PDBBind
Z59Ki:  96   nM  Binding MOAD
Biologically Interesting Molecules (External Reference) 1 Unique
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free: 0.225 
  • R-Value Work: 0.200 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 71.485α = 90
b = 76.213β = 90
c = 104.722γ = 90
Software Package:
Software NamePurpose
CrystalCleardata collection
AMoREphasing
BUSTERrefinement
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2009-11-10 
  • Released Date: 2009-12-22 
  • Deposition Author(s): Orth, P.

Revision History 

  • Version 1.0: 2009-12-22
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Non-polymer description, Version format compliance
  • Version 1.2: 2013-02-27
    Changes: Other